GRM2 and depressive symptom measurement: Therefore, mGlu2/5-HT2A receptor heterocomplex mediated signaling cannot be ignored in the context of synergistic modulation of these two main neurotransmitter systems in the pathophysiology of depression and AD action of halucinogens.